A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment

Edward Kerwina Clinical Research Institute of Southern Oregon, Medford, OR, USACorrespondence[email protected]

, md,

Paul Dorinskyb BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA

, md,

Mehul Patelc BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

, md, phd,

Kimberly Rossmand Formerly of BioPharmaceuticals R&D, AstraZeneca, Morristown, NJ, USA

, mba,

Colin Reisnerd Formerly of BioPharmaceuticals R&D, AstraZeneca, Morristown, NJ, USA

, md,

Andrea Maese Formerly of Biopharmaceuticals R&D, AstraZeneca, Wilmington, DE, USA

, phd,

Patrick Darkenf Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA

, phd,

Dianne Griffisb BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA

, phd &

Harald Fjällbrantg Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

, md, phd show all

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.